Janardan Khandekar to Prognosis
This is a "connection" page, showing publications Janardan Khandekar has written about Prognosis.
Connection Strength
0.045
-
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer. 2017 Dec 01; 123(23):4653-4662.
Score: 0.020
-
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Eur Urol. 2017 05; 71(5):740-747.
Score: 0.019
-
Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery. 1986 Mar; 18(3):335-40.
Score: 0.002
-
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60.
Score: 0.002
-
Urinary bladder metastases from breast carcinoma. Cancer. 1980 Jul 01; 46(1):229-32.
Score: 0.002